- Lilly announces three acquisitions to build infectious disease portfolio | Eli Lilly and Company investor.lilly.com
- Lilly Agrees to Buy Trio of Vaccine Developers WSJ
- Eli Lilly Will Buy Three Vaccine Developers The New York Times
- Lilly announces three acquisitions to build infectious disease portfolio PR Newswire
- Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals CNBC
Source link ← Back to News